Xu-chao Y. Zhang
No 106, Zhongshan Second Road
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 164 publications
FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36.
Journal: Science translational medicine
Published: August 26, 2026
ASO Visual Abstract: The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and Its Genomic Analysis.
Journal: Annals of surgical oncology
Published: August 11, 2026
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer.
Journal: Lung Cancer (Auckland, N.Z.)
Published: January 16, 2026
Comparing the effect of traditional and novel tyrosine kinase inhibitors for epidermal growth factor receptor exon 20 insertions by molecular dynamics simulation.
Journal: The Journal of international medical research
Published: December 16, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases.
Journal: Journal for immunotherapy of cancer
Published: October 26, 2025
Fenestrating Adenocarcinoma: A Novel Salivary Gland Cancer With EWSR1::BEND2 Fusion and Predilection for the Pharynx.
Journal: The American journal of surgical pathology
Published: October 23, 2025
The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and its Genomic Analysis.
Journal: Annals of surgical oncology
Published: August 15, 2025
Single-cell RNA profiling reveals an immunosuppressive microenvironment in EGFR double-mutant non-small cell lung cancer.
Journal: Translational lung cancer research
Published: June 19, 2025
Two new species of genus Leucoagaricus and Leucocoprinus (Agaricaceae, Agaricales) from China.
Journal: MycoKeys
Published: May 28, 2025
Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study.
Journal: Biomarker research
Published: May 24, 2025
The combination of immune checkpoint inhibitor and chemotherapy may be efficacious for advanced non-small cell lung cancer with near-loop insertions of EGFR exon 20: A retrospective analysis.
Journal: Science progress
Published: March 19, 2025
Last Updated: 09/26/2026